Filing Flows › Comparisons › AUPH vs RIGL
Aurinia Pharmaceuticals vs Rigel Pharmaceuticals: AUPH and RIGL compared
Aurinia Pharmaceuticals is the larger company: $83.7M of revenue in its latest quarter (Q3 2026) against $80.9M for Rigel Pharmaceuticals (Q3 2026). Rigel Pharmaceuticals is growing faster (+16% against +14% a year earlier). Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against 21.1%.
Where the money goes: AUPH and RIGL
Aurinia Pharmaceuticals (AUPH) · Q3 2026
Aurinia Pharmaceuticals, Q3 2026: revenue $83.7M (+14% year over year), operating margin 42.3%, net earnings $31.7M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
Rigel Pharmaceuticals (RIGL) · Q3 2026
Rigel Pharmaceuticals, Q3 2026: revenue $80.9M (+16% year over year), operating margin 21.1%, net earnings $13.2M, operating cash flow $34.6M. The chart follows the revenue to costs, profit and cash.
| Aurinia Pharmaceuticals (AUPH) | Rigel Pharmaceuticals (RIGL) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $83.7M | $80.9M |
| Revenue growth, Y/Y | +14% | +16% |
| Operating margin | 42.3% | 21.1% |
| Net earnings | $31.7M | $13.2M |
| Net margin | 37.9% | 16.3% |
| Operating cash flow | $46.4M | $34.6M |
| Market value | $2.2B | — |
| P/E | 7.2× | — |
| Analysts’ mean target | $18.29 | — |
Where the revenue comes from
Aurinia Pharmaceuticals
- Net product sales: $79.4M (95%)
- License, collaboration and royalty revenue: $4.3M (5%)
Rigel Pharmaceuticals
- Product sales, net: $72.3M (89%)
- Contract revenues from collaborations and other: $8.6M (11%)
Questions
Which is bigger, Aurinia Pharmaceuticals or Rigel Pharmaceuticals?
Aurinia Pharmaceuticals is the larger company: $83.7M of revenue in its latest quarter (Q3 2026) against $80.9M for Rigel Pharmaceuticals (Q3 2026).
Is Aurinia Pharmaceuticals or Rigel Pharmaceuticals growing faster?
Rigel Pharmaceuticals is growing faster (+16% against +14% a year earlier).
Which is more profitable, Aurinia Pharmaceuticals or Rigel Pharmaceuticals?
Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against 21.1%.
More: Aurinia Pharmaceuticals earnings · how Aurinia Pharmaceuticals makes money · Rigel Pharmaceuticals earnings · how Rigel Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 30, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.